In line with this, our cytokine analysis identified IFN-g as a shared positive associate of both TIGIT and CD155, which is consistent with the idea that immune activation and compensatory checkpoint upregulation can co-occur in tumor tissue. The gene discussed is TIGIT; the disease is neoplasm.